Search results
Results From The WOW.Com Content Network
Approximately 15–50% of people who suddenly stop an antidepressant develop antidepressant discontinuation syndrome. [7] [2] [3] [4] The condition is generally not serious, [2] though about half of people with symptoms describe them as severe. [4] Many restart antidepressants due to the severity of the symptoms. [4]
Abruptly stopping sertraline before your next dose could lead to uncomfortable withdrawal symptoms, including eye pain, nausea, headaches, irritability, nightmares or frequent thoughts about death.
The review found Ms Wang was informed of the need to stop antidepressants carefully and was sent a link to information about sertraline. ... a spokesperson said its “guidance advises prescribers ...
Don’t stop your current antidepressant or adjust your dosage without professional guidance. This could cause you to experience antidepressant withdrawal symptoms or a relapse of your depression ...
Sertraline, sold under the brand name Zoloft among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class [10] used to treat major depressive disorder, generalized anxiety disorder, social anxiety disorder, obsessive–compulsive disorder (OCD), panic disorder, and premenstrual dysphoric disorder. [11]
Peer support groups, such as survivingantidepressants.org, provide a medium where those tapering medication can discuss approaches and withdrawal symptoms. [12] Surviving antidepressants advocate for a slower rate of tapering than that used in standard medical practice.
Martin Kingston told BBC Radio 4’s Today programme that he believed more people should be told explicitly the potential side effects of SSRIs and what can happen if they stop taking them.
The stopping of antidepressants for example, can lead to antidepressant discontinuation syndrome. With careful physician attention, however, medication prioritization and discontinuation can decrease costs, simplify prescription regimens, decrease risks of adverse drug events and poly-pharmacy, focus therapies where they are most effective, and ...